SCHEMBL31649045

SCHEMBL31649045

N[C@H](CN1C(=O)c2ccccc2C1=O)C(=O)N1CCC[C@H]2CCCC[C@@H]21

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DPP7 Q9UHL4 5/20 0.47
▸ DPP4 P27487 10/20 0.46
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ DPP8 Q6V1X1 6/20 0.42
▸ DPP9 Q86TI2 6/20 0.42
▸ FAP Q12884 5/20 0.42
▸ HTR1A P08908 1/20 0.41
▸ HTR7 P34969 1/20 0.41
▸ HRH1 P35367 1/20 0.41
▸ DRD3 P35462 1/20 0.41
▸ HTR2B P41595 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ HSD11B1 P28845 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31649183 0.88 DPP7 (0.51) DPP7DPP4NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL31649315 0.85 DPP4 (0.52) DPP7DPP4NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL31649106 0.85 HTR1A (0.52) DPP7DPP4SMN1; SMN2DPP8DPP9
SCHEMBL770503 0.79 HSD17B10 (0.56) DPP4NPC1RAB9ASMN1; SMN2DPP8
SCHEMBL770733 0.77 ALDH1A1 (0.58) SMN1; SMN2HTR1AHTR7HRH1DRD3
SCHEMBL31649265 0.76 ACE (0.45) NPC1RAB9ASMN1; SMN2
SCHEMBL31649395 0.76 DRD2 (0.45) DPP7DPP4NPC1RAB9ASMN1; SMN2
SCHEMBL31649050 0.75 DPP7 (0.60) DPP7DPP4NPC1RAB9ASMN1; SMN2
SCHEMBL770858 0.75 ACHE (0.60) SMN1; SMN2HTR1AHTR7HRH1DRD3
SCHEMBL15377479 0.74 ALDH1A1 (0.56) SMN1; SMN2HTR1AHTR7HRH1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025132943-A1 DECAHYDROQUINOLINES AS DNA POLYMERASE THETA INHIBITORS BREAKPOINT THERAPEUTICS GMBH (DE) 2025-06-26 — — WO disclosed
Send feedback